RNA-based gene therapies for genetic heart diseases (laminopathies).
| Date | Round | Amount |
|---|---|---|
| Nov 2024 | Funding round Dutch biotech Phlox Therapeutics raised EUR 1.9M, adding ROM Utrecht Region to its syndicate, to advance RNA therapies for genetic heart diseases. | $2M |